Keigo Shibayama
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 75
- Endocrinology top 0.2%
- Enterobacteriaceae and Cronobacter Research 19
- Microbiology top 0.5%
- Bacterial Infections and Vaccines 24
- Pollution top 1%
-
- Pneumonia and Respiratory Infections 36
- Mycobacterium research and diagnosis 29
-
- Helicobacter pylori-related gastroenterology studies 29
-
- Streptococcal Infections and Treatments 26
-
- Bacterial biofilms and quorum sensing 18
Keigo Shibayama
224 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 137
- Molecular Medicine 3.0k
- Endocrinology 1.5k
- Applied Microbiology and Biotechnology 435
- Microbiology 655
- Pollution 707
Countries citing papers authored by Keigo Shibayama
This map shows the geographic impact of Keigo Shibayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keigo Shibayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keigo Shibayama more than expected).
Fields of papers citing papers by Keigo Shibayama
This network shows the impact of papers produced by Keigo Shibayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keigo Shibayama. The network helps show where Keigo Shibayama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keigo Shibayama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 40 | |
| 7 | 2021 | 20 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 27 | |
| 11 | 2018 | 36 | |
| 12 | 2017 | 21 | |
| 13 | 2014 | 8 | |
| 14 | 2014 | 21 | |
| 15 | 2013 | 8 | |
| 16 | 2013 | 30 | |
| 17 | 2012 | 7 | |
| 18 | 2011 | 7 | |
| 19 | 2004 | 0 | |
| 20 | 2003 | 171 |
About Keigo Shibayama
Keigo Shibayama is a scholar working on Molecular Medicine, Endocrinology and Microbiology, having authored 228 papers that have together received 6.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (75 papers), Pneumonia and Respiratory Infections (36 papers), Mycobacterium research and diagnosis (29 papers), Helicobacter pylori-related gastroenterology studies (29 papers), Streptococcal Infections and Treatments (26 papers), Bacterial Infections and Vaccines (24 papers), Enterobacteriaceae and Cronobacter Research (19 papers) and Bacterial biofilms and quorum sensing (18 papers). The work is most often cited by research in Molecular Medicine (3.0k citations), Endocrinology (1.5k citations) and Applied Microbiology and Biotechnology (435 citations). Keigo Shibayama has collaborated with scholars based in Japan, United States and Vietnam. Frequent co-authors include Yoshichika Arakawa, Naohiro Shibata, Hiroshi Kurokawa, Tetsuya Yagi, Kunikazu Yamane, Satowa Suzuki, Haru Kato, Jun‐ichi Wachino, Kouji Kimura and Yohei Doi. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.